|Videos|January 8, 2021
Choosing Between Vancomycin and Fidaxomicin for C. Difficile Infections
Implications for prescribing vancomycin or fidaxomicin to treat C. difficile infections.
Advertisement
Episodes in this series
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Antibiotic De-Escalation Demonstrates Advantages for Community-Onset Sepsis
2
Vigilance, Training, and Funding are Key for Outbreak and Pandemic Biopreparedness
3
Top Infectious Disease News Stories Week of December 20 - December 26
4
From Awareness to Prevention: Addressing the Infection–Mental Illness–Violence Continuum
5